ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671031 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671031; 2) Community: the network communities that were significantly associated with the response to NSC 671031; 3) Molecule: the relationships between components within communities and NSC 671031; 4) MDR: the compounds that were significantly associated with the NSC 671031.

NSC Compound Enrichment Correlation
NSC 6926 Null 0.0236268253072453 0.24917073
NSC 694619 Null 0.0236268253072453 0.33446262
NSC 718630 Null 0.0236268253072453 0.3012949
NSC 718781 Erlotinib hydrochloride 0.0236268253072453 -0.41957422
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0236268253072453 0.44984949
NSC 727620 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride 0.0236268253072453 0.47258848
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0236268253072453 0.15600909
NSC 743532 Null 0.0236268253072453 -0.00012121647
NSC 744688 Null 0.0236268253072453 0.34379874
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0236268253072453 0.17402647
Total:64  Current:35    [First] [Prev] [Next] [Last]